Additionally, the NLRP3 inflammasome has been linked to the development of myeloid leukemias, such as chronic myelomonocytic leukemia (CMML), juvenile myelomonocytic leukemia (JMML), and AML, particularly in the context of KRAS mutations [60,61,62]. This evidence concerns the gene KRAS and chronic myelomonocytic leukemia.